Thursday, July 26, 2018

GlaxoSmithKline announces $300 million equity investment in 23andMe

This is an important way to capture important genomic information, says Hal Barron, GlaxoSmithKline chief scientific officer, and Richard Scheller, 23andMe chief scientific officer talking about GSK's investment into the personal genetic company.

from Top Video https://ift.tt/2OkGT2a

No comments:

Post a Comment

Wikipedia article of the day for September 2, 2020

The Wikipedia article of the day for September 2, 2020 is Third Silesian War . The Third Silesian War was a conflict between Prussia and a...